Web Analytics

3 Latest Announced Rounds

$2,242.25M Raised in 70 Funding Rounds in the past 7 Days - View All

Funding Round Profile

OncoLens

start up
United States - Atlanta, Georgia
  • 17/07/2023
  • Unknown
  • Undisclosed Amount

An AI driven oncology care platform that delivers next level multidisciplinary team collaboration, analytics and clinical decision support tools.
The OncoLens platform:
• Integrates patient data across disparate data systems including EMRs, genomics, PACS, pathology and more.
• Extracts actionable informatics from structured and unstructured data to identify patients for clinical trials, biomarker testing, stem cell therapies and more.
• Enables multi-disciplinary care team collaboration within and across enterprises.

Contact us at info@oncolens.com for a demo.


Related People

Anju MathewCo Founder

Anju Mathew United States - Atlanta Metropolitan Area

It’s hard to find someone in today’s world who has not been impacted by cancer, whether having it themselves or through the diagnosis of a loved one. My personal experience with cancer in my family highlighted opportunities to deliver cancer care more efficiently, especially in reducing the time to market awareness and use of the latest potential therapies. This led me to my current role as CEO and co-founder of OncoLens.

OncoLens delivers innovative solutions for tumor board management, survivorship care planning, accreditation and quality improvement. OncoLens envisions a world where every cancer patient has access to the best possible minds, therapies and innovations in care – in time to make a difference. I am extremely proud of our award-winning company and our ability to pivot and change as needs arise.

Prior to launching OncoLens, I was the head of technology and innovation at McKesson’s Medical Surgical business unit where I led the development and launch of several successful tools and business partnerships. I also served in McKesson’s corporate strategy group.

My first startup was a medical device company in the cancer-imaging space, LumaMed. I have also had the privilege of working with Thomson-Reuters, A. T. Kearney, IBM and i2 Technologies.

I am passionate about entrepreneurship and innovation as a way to creatively solve problems while also positively impacting the economy. I am proud to be a member of the Atlanta Technology Angels group and a former member of the board of directors for Illuma Care Connections.

Learn more at www.oncolens.com.